Márquez-Rodas, Iván; Dutriaux, Caroline; Saiag, Philippe; de-la-Cruz-Merino, Luis; Castañon-Álvarez, Eduardo; Robert, Caroline; Rodríguez-Moreno, Juan-F; Arance, Ana; Cerezuela-Fuentes, Pablo; Montaudie, Henri; Fernández-de-Sanmamed-Girón, Miguel; González-Cao, María; Charles, Julie; López-Criado, María-Pilar; Berrocal, Alfonso; de-Miguel, Enrique; Funck-Brentano, Elisa; Prey, Sorilla; Álamo-de-la-Gala, María-del-Carmen; Melero, Ignacio; Avilés-Izquierdo, José-Antonio; Roman, Ruth; García-Pelaez, Beatriz; Rodríguez, Sonia; Trnkova, Zuzana-Jirakova; Quintero, Marisol; Macia, Sonia; Chaney, Marya-F; Dalle, Stephane
(LIPPINCOTT WILLIAMS & WILKINS, 2025-09)
PURPOSE: Patients with anti-PD-1-resistant melanoma (MEL) have no well-defined standard of care. BO-112 is a synthetic, double-stranded RNA (poly I:C) nanoplexed with polyethylenimine that when administered intratumorally ...